Emi Matsuo

Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience

Hidehiro Itonaga, Hideki Tsushima, Jun Taguchi et al. · Blood · 2012 · 71 citations

Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study Group

Mari Sakai, Yasushi Miyazaki, Emi Matsuo et al. · International Journal of Hematology · 2009 · 43 citations

Practical Setting, Imatinib Trough Concentration, Oncology +3

Distinct Clinical Features of Infectious Complications in Adult T Cell Leukemia/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis in the Nagasaki Transplant Group

Hidehiro Itonaga, Jun Taguchi, Takuya Fukushima et al. · Biology of Blood and Marrow Transplantation · 2013 · 33 citations · Full text

Immunology, Transplantation Medicine, Pathology +20

Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: a retrospective analysis of the Nagasaki Transplantation Network

Takuya Fukushima, Hidehiro Itonaga, Yukiyoshi Moriuchi et al. · International Journal of Hematology · 2013 · 32 citations · Full text

Cell Therapy, Transplantation, Marrow Transplantation +13

Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa

Hidehiro Itonaga, Hideki Tsushima, Tomoko Hata et al. · International Journal of Hematology · 2012 · 27 citations · Full text

Hematological Malignancy, Successful Treatment, Medicine +8